News

European Media Contact

Thomas Schneckenburger
thomas.schneckenburger@molecularpartners.com
Tel: +41 44 755 5728

U.S. Media Contact

Tom Donovan
tom@tenbridgecommunications.com
Tel: +1 857 559 3397

Press Releases

July 2020

Molecular Partners successfully completes Private Placement of 5,528,089 Shares by way of an Accelerated Bookbuilding

July 2020

Molecular Partners announces the launch of a Private Placement of Shares by way of an Accelerated Bookbuilding

June 2020

Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol

View All News >>

In the News

May 2019

Taking a Drug to Market “Is a Marathon, Not a Sprint”

July 2018

Allergan and Molecular Partners release positive Phase III data on AMD drug

July 2018

In two PhIII wins for Allergan/Molecular Partners, wet AMD drug shows non-inferiority to Lucentis

View More In the News >>